Evidence map›Paper›PMID 36035740›Full record

ArticleCJC open2022

The State of Heart Failure Care in Canada: Minimal Improvement in Readmissions Over Time Despite an Increased Number of Evidence-Based Therapies.

Stephanie Poon, Benjamin Leis, Laurie Lambert, Kendra MacFarlane, Kim Anderson, Claudia Blais, Catherine Demers, Justin A Ezekowitz, Nathaniel M Hawkins, Douglas S Lee and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CJC open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Status of βReviews in cardiovascular medicine · 2023
    Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Stephanie PoonDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Benjamin LeisDepartment of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Laurie LambertCanadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada.
Kendra MacFarlaneCanadian Cardiovascular Society, Ottawa, Ontario, Canada.
Kim AndersonDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Claudia BlaisInstitut national de santé publique du Québec (INSPQ), Université Laval, Quebec City, Quebec, Canada.
Catherine DemersDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada.
Justin A EzekowitzDepartment of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Nathaniel M HawkinsDepartment of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Douglas S LeeDepartment of Medicine, Institute for Clinical Evaluative Sciences, University Health Network, Toronto, Ontario, Canada.
Gordon MoeDepartment of Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
Roopinder K SandhuSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Sean A ViraniDivision of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Stephen WiltonLibin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
Shelley ZierothDepartment of Medicine, St. Boniface General Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.
Robert McKelvieDepartment of Medicine, Western University and St. Joseph's Health Care, London, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: An unanswered question is whether the combination of advances in medical and device therapy over the past decade has translated into improved outcomes for patients with heart failure (HF) in Canada. Methods: The Canadian Institute for Health Information (CIHI) Hospital Morbidity Database was used to identify hospitalizations for HF among patients aged 18 years and older in Canadian hospitals during fiscal years 2009/2010 and 2018/2019. We assessed interprovincial differences in age, sex, length of stay (LOS), discharge disposition, type of admitting hospital, and most responsible service, for all HF admissions. National and provincial rates of HF admissions and all-cause 30-day readmissions were calculated. Results: After adjusting for age, the rate of HF admissions in Canada was 216 per 100,000 population in 2009/2010 and 2018/2019. The majority of patients with HF were admitted to general internal medicine and community hospitals in both 2009/2010 and 2018/2019. The national, crude, all-cause 30-day readmission rate stayed constant at 20.6%, and the majority of patients were readmitted with the diagnosis of HF in both 2009/2010 (62.5%) and 2018/2019 (59.0%). Median and interquartile range of HF LOS also remained unchanged at 7 days (3-14). Conclusions: The national rate of HF admissions, 30-day readmissions, and HF LOS have remained unchanged from 2009/2010 to 2018/2019, despite advances in medical and device therapy during this timeframe.

Identifiers

PMID36035740
PMCPMC9402962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.